8.3 C
London, UK
Friday, 29, March, 2024

Tag: Spravato

John Read – UK Esketamine Approval – Not so Fast

An interview with Professor John Read who joins us to discuss the UK licensing of esketamine nasal spray (Spravato) for so-called ‘Treatment Resistant Depression’. John led a group of 12 academics and professionals who wrote to the UK regulator expressing concerns.